RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research
Abstract
«Budget impact analysis» method gives an opportunity to assess the expected costs of the budget for the phases before and after the introduction of new technology and/or a combination of technologies in certain nosology. The result is the ability to predict the change in budgetary expenditure, as well as to evaluate the acceptability of such changes for the budgetary financing of healthcare.
About the Authors
V. V. RyazhenovRussian Federation
S. G. Gorokhova
Russian Federation
N. D. Bunyatyan
Russian Federation
References
1. Отраслевой стандарт «Клинико-экономические исследования. Общие
2. положения» (ОСТ 91500.14.0001-2002) // Проблемы стандартизации в
3. здравоохранении. 2002. № 5. С. 55–67.
4. Ряженов В.В. Фармакоэкономический анализ применения пегилированных
5. интерферонов альфа при хроническом гепатите С: клинико-экономический анализ // Инфекционные болезни. 2010; 4:72–78.
6. Araujo D.V., Lima V.C., Ferraz M.B. Impact analysis of drug-eluting stent in the unified health system budget // Arq Bras Cardiol. 2007; 88(4): 458–63.
7. Gani R., Griffin J., Kelly S. et al. Economic analyses comparing tiotropium with ipratropium or salmeterol in UK patients with COPD // Prim Care Respir J. 2010;19(1):68–74.
8. Mauskopf J.A., Sullivan S.D., Annemans L., Caro J. et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices-budget impact analysis // Value Health. 007;10(5):336–347.
9. Moreu J., Cequier A., Brosa M. et al. Economic evaluation and budget impact analysis of the Endeavor drug-eluting stent in Spain // Gac Sanit. 2009; Nov–Dec;23(6):540–547.
Review
For citations:
Ryazhenov V.V., Gorokhova S.G., Bunyatyan N.D. RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research. Regulatory Research and Medicine Evaluation. 2011;(1):56-59. (In Russ.)
Views:
333
Email this article 